Instrument Business Outlook Volume 32 - Issue 19: Annual 2024 Forecast
17 Jan 2024
Categories:
Instrument Business Outlook
Table of Contents
-
The IBO 2024 Market Forecast
- 2023
- 2024
- Economic Overview
- Life Science Instrumentation: A Bumpy Road Ahead
- The Mass Spectrometry Market to Experience Slower Growth in 2024
- Gloomy Market Pressures Chromatography
- Lab Automation: End-Market Lethargy Mutes Software Growth Prospects
- Surface Science Growth Slows on the Wings on Weakening China and Pharma Growth
- Molecular Spectroscopy Bridges Contrasts: Understanding Pharma & Biotech Softness and Academic Growth
- Atomic Spectroscopy: Market Favors Techniques with Broad Applications and Better Performance
- Sample Preparation: Destocking Reins in Growth
- Materials Characterization: Advanced Materials in the Driver’s Seat
- Lab Equipment Markets to Move from Flat to Growth in 2024
- End-Market Forecast: Pharma Begins its Recovery, Industrial Customers Cool
- Regional Forecast: Asia (Excluding China and Japan) Offers Greatest Potential
-
2023 Trends and Developments
- China’s Surprising Turn
- Pharma & Biotech’s Pause
- Shareholders Make Noise
- Funding Troubles Remain
- Workforce Reductions
-
Executive Briefing
- Ilumina Acquires Partek
- Standard BioTools and SomaLogic Complete Merger
- Biotage CEO Steps Down
- Dotmatics Makes 13th Acquisition
- NanoString Further Reduces Workforce
- ABB Buys Water Quality Monitoring Technology Company
- Calibre Scientific Acquires German Supplier
- Mabtech Sold
- Parse Expands to Software
- LIMS Vendors Form New Company
- Oxford Instruments Buys Scientific Camera Company
- Flow Reactor Maker Sold
-
J.P. Morgan Healthcare Conference 2024: Lab Tool Companies Provide Updates and Reflect on End-Market Strength
- Illumina
- Bruker
- NanoString Technologies
- Agilent, Danaher, Revvity, Thermo Fisher Scientific and Waters